HALOPERIDOL ARENA 2mg tablets medication leaflet

N05AD01 haloperidol • Nervous system | Antipsychotics | Butyrophenone derivatives

Haloperidol is an antipsychotic medication from the butyrophenone class, used to treat severe mental disorders such as schizophrenia, bipolar disorder, and acute psychotic episodes. It is also used to control severe agitation, aggressive behavior, and tics associated with Tourette syndrome.

Haloperidol works by blocking dopamine receptors in the brain, helping to reduce symptoms such as hallucinations, delusions, and disorganized thinking. It is also effective in reducing severe nausea and vomiting, particularly in the context of cancer treatments.

Side effects may include drowsiness, muscle stiffness, tremors, dizziness, or an increased risk of extrapyramidal symptoms (involuntary movements). In rare cases, it can cause neuroleptic malignant syndrome, a serious condition. It is important for the medication to be administered under strict medical supervision.

General data about HALOPERIDOL ARENA 2mg

Substance: haloperidol

Date of last drug list: 01-03-2022

Commercial code: W60384001

Concentration: 2mg

Pharmaceutical form: tablets

Quantity: 30

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ARENA GROUP S.A. - ROMANIA

Holder: ARENA GROUP S.A. - ROMANIA

Number: 5997/2013/01

Shelf life: 3 years

Pharmaceutical forms available for haloperidol

Concentrations available for haloperidol

0.5mg, 1mg, 2mg, 2mg/ml, 50mg/ml, 5mg, 5mg/ml

Other substances similar to haloperidol